DexCom Balance Sheet Health
Financial Health criteria checks 6/6
DexCom has a total shareholder equity of $2.2B and total debt of $2.4B, which brings its debt-to-equity ratio to 108.4%. Its total assets and total liabilities are $6.5B and $4.2B respectively. DexCom's EBIT is $651.6M making its interest coverage ratio -5.1. It has cash and short-term investments of $2.9B.
Key information
108.4%
Debt to equity ratio
US$2.44b
Debt
Interest coverage ratio | -5.1x |
Cash | US$2.90b |
Equity | US$2.25b |
Total liabilities | US$4.24b |
Total assets | US$6.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DC4's short term assets ($4.6B) exceed its short term liabilities ($1.6B).
Long Term Liabilities: DC4's short term assets ($4.6B) exceed its long term liabilities ($2.6B).
Debt to Equity History and Analysis
Debt Level: DC4 has more cash than its total debt.
Reducing Debt: DC4's debt to equity ratio has reduced from 152.9% to 108.4% over the past 5 years.
Debt Coverage: DC4's debt is well covered by operating cash flow (32.9%).
Interest Coverage: DC4 earns more interest than it pays, so coverage of interest payments is not a concern.